Search | IOVS | ARVO Journals

View

Showing 1 – 11 of 11

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Using retinal structural measurements derived from optical coherence tomography as clinical endpoints for Stargardt disease - reproducibility assessment and lessons learned from the ProgStar study

Xiangrong Kong; Alexander Ho; Beatriz Munoz; Sheila K West; Rupert W Strauss; Anamika Jha; Ann Margret Ervin; Janet Cheetham; Michael S Ip; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3945. doi:

New Developments in Vision Research April 2019

A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned

PDF

Ann-Margret Ervin; Rupert W. Strauss; Mohamed I. Ahmed; David Birch; Janet Cheetham; Frederick L. Ferris III; Michael S. Ip; Glenn J. Jaffe; Maureen G. Maguire; Etienne M. Schönbach; SriniVas R. Sadda; Sheila K. West; Hendrik P.N. Scholl; for the ProgStar Study Group
TAGS: atrophy, eye, spectral domain-optical coherence tomography, stargardt's disease, prospective studies
Trans. Vis. Sci. Tech.. 2019; 8(2):16. doi: https://doi.org/10.1167/tvst.8.2.16

ARVO Annual Meeting Abstract June 2017

Natural progression of scotopic and photopic macular function loss in patients with Stargardt disease: The SMART Study.

Millena Bittencourt; Mohamed A Ibrahim; Xiangrong Kong; Rupert Wolfgang Strauss; Ann-Margret Ervin; Alexander Ho; Muneeswar Gupta Nittala; Isabelle S Audo; David G Birch; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3281. doi:

ARVO Annual Meeting Abstract June 2017

Visual acuity loss during two years in Stargardt Disease: The ProgStar Study

Xiangrong Kong; Rupert Wolfgang Strauss; Beatriz Munoz; Ann-Margret Ervin; Artur V Cideciyan; Michel Michaelides; Mohamed Ahmed; Janet Cheetham; Sheila West; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4647. doi:

ARVO Annual Meeting Abstract September 2016

Progression of visual acuity and fundus autofluorescence in recent onset Stargardt disease: ProgStar study

Sheila K West; Xiangrong Kong; Beatriz E Munoz; Artur V Cideciyan; Michel Michaelides; Ann-Margret Ervin; Srinivas R Sadda; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2687. doi:

ARVO Annual Meeting Abstract September 2016

The natural history of the progression of atrophy secondary to Stargardt disease type 4 (Progstar-4 Study): Baseline demographics and ocular characteristics of patients with PROM-1 related retinal dystrophy.

Syed Mahmood Ali Shah; Mohamed Ahmed; Nadia Junaid; Saghar Bagheri; Beatriz E Munoz; Rupert Wolfgang Strauss; Etienne M. Schonbach; Michel Michaelides; Ann-Margret Ervin; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2695. doi:

ARVO Annual Meeting Abstract September 2016

Scotopic and photopic macular functions as assessed with microperimetry (MP1) in patients with Stargardt disease type 1 – The SMART Study

Mohamed A Ibrahim; Rupert Wolfgang Strauss; Xiangrong Kong; Ann-Margret Ervin; Alexander Ho; Janet S Sunness; Isabelle S Audo; David G Birch; Srinivas R Sadda; Millena G Bittencourt; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2696. doi:

ARVO Annual Meeting Abstract September 2016

Visual acuity loss during one year in Stargardt Disease: ProgStar Prospective Study

Xiangrong Kong; Rupert Wolfgang Strauss; Ann-Margret Ervin; Paul S Bernstein; Artur V Cideciyan; Janet S Sunness; Elias I Traboulsi; Beatriz E Munoz; Mohamed Ahmed; Sheila K West; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract September 2016

Baseline characteristics of subjects enrolled in the trial of lutein and zeaxanthin supplementation and its effect on macular pigment in albinism (LUVIA Study: Lutein for Vision in Albinism)

Saghar Bagheri; Yulia Wolfson; Beatriz E Munoz; Ann-Margret Ervin; Mohamed A Ibrahim; Mary Frey; Simrat K Sodhi; Syed Mahmood Ali Shah; Sheila K West; Hendrik P Scholl

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5158. doi:

ARVO Annual Meeting Abstract June 2015

The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Baseline Demographics and Ocular Characteristics

Ann-Margret Ervin; Beatriz E Munoz; Rupert Wolfgang Strauss; Yulia Wolfson; Xiangrong Kong; Sheila K West; Hendrik P Scholl; ProgStar Study Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1781. doi:

ARVO Annual Meeting Abstract March 2012

Characteristics Of Randomized Trials In Ophthalmology Using A Within-person Paired Design

Roberta W. Scherer; Jennifer Breck; Ann-Margret Ervin; US Cochrane Eyes and Vision Group

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4734. doi:

Advertisement